This randomized trial demonstrates enhanced detection of small molecules in pharmaceuticals, suggesting improved analytical methods for PFAS characterization.
F DNP for small-molecule NMR in analytical and pharmaceutical chemistry, and eventually for the detection and characterization of environmentally persistent PFAS compounds.
No takes yet. Share an insight, caveat, or question.
Wi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: